Protherics PLC
Notification of Interests
Directors and Persons Discharging Managerial Responsibility
London, UK; Brentwood, TN, US; 10 June 2008 - Protherics PLC
("Protherics" or the "Company"), the international biopharmaceutical
company focused on critical care and cancer, Protherics PLC announces
the grant, on 9 June 2008, of the following options over Ordinary
Shares in Protherics ("Ordinary Shares") to Directors and other Persons
Discharging Managerial Responsibility (PDMRs) under the terms of
the Protherics PLC Long Term Incentive Plan ("LTIP"):
Name Position Number
of Options
Directors:
Andrew Heath Chief Executive Officer 500,000
Rolf Soderstrom Finance Director 313,513
James Christie Operations Director 270,270
PDMRs:
Ian Scoular Director of Business Development 227,027
Nick Staples Director of Corporate Affairs 191,891
Sally Waterman Director of Research & Development 227,027
The options are exercisable between the third and tenth anniversary of
the date of grant at an exercise price of 2p per share, subject to the
achievement of performance conditions.
Protherics also announces the award, on 9 June 2008, of a conditional
right to receive 252,460 Ordinary Shares under the terms of the
LTIP, to Saul Komisar, President of the Company's US operations.
The award vests on the third anniversary of the date of grant subject
to the achievement of performance conditions.
In addition to the above, the following Directors and PDMRs were
granted options under the terms of the Deferred Bonus Plan on 9 June
2008:
Number of
Directors: Options
Rolf Soderstrom 99,099
James Christie 128,378
PDMRs:
Sally Waterman 86,486
Nick Staples 72,972
The options are exercisable between the second and tenth anniversary of
the date of grant at an exercise price of 2p per share.
Following the above grant of options and share awards, the
Company's Directors and PDMRs hold options or share awards over the
following number of Ordinary Shares:
Number of Shares
Andrew Heath 4,523,909
Rolf Soderstrom 1,040,339
James Christie 1,851,986
Saul Komisar 1,523,541
Ian Scoular 1,348,758
Nick Staples 871,114
Sally Waterman 993,023
/ Ends /
For further information please contact:
Protherics
Nick Staples, Director of Corporate Affairs +44 (0) 7919 480510
Julie Vickers, Company Secretary +44 (0)1928 518010
Financial Dynamics - press enquiries
London: Ben Atwell, Lara Mott +44 (0) 20 7831 3113
New York: John Capodanno, Jonathan Birt +1 212 850 5600
Or visit www.protherics.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com